I think we have less than 1 month before we see whether our COVID offering has legs. Even if it achieves half of the prior mini trial, it could be pushed heavily as US / Europe opens up and cases / deaths trend much higher. Plus the longer it goes on, the more death will weigh on governments and votes.
Ok - the downside. Prior to COVID spike in share price, MSB had a run to $3 based on all the other progress. If COVID offeirng does not play out, they cleverly raised capital at a great price and can now execute business as usual this year.
Phase 3 results for Heart Failure and Back Discs - the latter would be ideal if we don't get both.
I don't think the long term upside is based into MSB. Yes could drop but this has all the makings of another CSL.
Emperor wearing any clothes
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |